However, NSCLC with increased B7-H3 expression showed a higher number of tumor-infiltrating CD45+ immune cells, natural killer (NK) cells, and CD8+ T cells, suggesting a prognostic role for B7-H3 in immunotherapy [5]. The gene discussed is CD276; the disease is non-small cell lung carcinoma.